Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-016001
Filing Date
2017-08-07
Accepted
2017-08-07 16:16:50
Documents
46
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q kura-10q_20170630.htm 10-Q 1565016
2 EX-10.2 kura-ex102_266.htm EX-10.2 19273
3 EX-31.1 kura-ex311_7.htm EX-31.1 17189
4 EX-31.2 kura-ex312_6.htm EX-31.2 16955
5 EX-32.1 kura-ex321_9.htm EX-32.1 9620
  Complete submission text file 0001564590-17-016001.txt   5056358

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT kura-20170630.xml EX-101.INS 1161656
7 XBRL TAXONOMY EXTENSION SCHEMA kura-20170630.xsd EX-101.SCH 32741
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE kura-20170630_cal.xml EX-101.CAL 40526
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE kura-20170630_def.xml EX-101.DEF 81898
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE kura-20170630_lab.xml EX-101.LAB 237917
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kura-20170630_pre.xml EX-101.PRE 168493
Mailing Address 11119 N. TORREY PINES ROAD, STE 125 LA JOLLA CA 92037
Business Address 11119 N. TORREY PINES ROAD, STE 125 LA JOLLA CA 92037 (858) 500-8800
Kura Oncology, Inc. (Filer) CIK: 0001422143 (see all company filings)

IRS No.: 611547851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37620 | Film No.: 171011684
SIC: 2834 Pharmaceutical Preparations